Insight

Philippe Spiess: The role of neoadjuvant systemic therapy for high grade upper tract urothelial carcinoma

oncologynewscentral.com

Dec 26, 2024, 12:53

Philippe Spiess: The role of neoadjuvant systemic therapy for high grade upper tract urothelial carcinoma

Philippe Spiess, Assistant Chief of Surgery and Senior Member, Department of GU Oncology at Moffitt Cancer Center, shared a post on X:

“The role of neoadjuvant systemic therapy for high grade upper tract urothelial carcinoma: Results from the upper tract collaborative network (UCAN) – ScienceDirect.”

The role of neoadjuvant systemic therapy for high grade upper tract urothelial carcinoma: Results from the upper tract collaborative network (UCAN)

Authors: Gianpaolo P. Carpinito, Thomas Gerald, Patrick J. Hensley, Austin J. Martin, Maximilian Pallauf, Jonathan Pham, Roger Li, Aaron M. Potretzke, Philippe E. Spiess, Nirmish Singla, Jay D. Raman, Jonathan Coleman, Surena F. Matin, Vitaly Margulis

Philippe Spiess

Aaron M. Potretzke Austin J. Martin cancer Gianpaolo P. Carpinito Jay D. Raman Jonathan Coleman Jonathan Pham Maximilian Pallauf Nirmish Singla OncoDaily Oncology Patrick J. Hensley Philippe E. Spiess Philippe Spiess Roger Li Surena F. Matin Thomas Gerald urothelial carcinoma Vitaly Margulis

Oncologist Near Me – Fedro Alessandro Peccatori: Leading Expert in Gynecological Oncology

MATTERHORN trial - FLOT plus durvalumab will become the new standard of care in the preoperative setting for gastroesophageal cancer

Daiichi Sankyo's and Astrazeneca's press release on ENHERTU®: Latest Updates from DESTINY-Gastric04 trial

13-year-old Cancer Survivor Sworn in as a Secret Service agent by President Trump - The White House

The European Parliament Intergroup on Cancer and Rare Diseases has been set in motion - ECO